# Rein Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:67998b7c-0281-4502-838a-bd3dac6c8ea2 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/rein-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 21 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-18T07:13:20.270492+00:00 | | Last reviewed | 2026-10-18T07:13:20.270492+00:00 | ## Identity - Legal name: Rein Therapeutics, Inc. - Display name: Rein Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-18T09:21:42.455789+00:00 | | Completeness | 0.409 | | Record Quality | 0.835 | | Directors | 6 | | Committees | 6 | | Governance events | 14 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Alan A. Musso: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:5 - Brian Windsor, Ph.D.: Director. Status: current. Independent: false. Since: 2023-01-01. claim_id=alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:6 - Josef H. von Rickenbach: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (member); Audit; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:7 - Manuel C. Alves Aivado, M.D., Ph.D.: Director. Status: current. Independent: false. Since: 2018-01-01. claim_id=alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:8 - Reinhard J. Ambros, Ph.D.: Director. Status: current. Independent: true. Since: 2013-01-01. claim_id=alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:9 - William C. Fairey: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Compensation (member); Compensation; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:10 ## Committees - Audit (audit). Chair: Alan A. Musso. Members: Alan A. Musso (chair, current); Josef H. von Rickenbach (member, current). committee_id=alpha:committee:rein-therapeutics-inc:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Alan A. Musso (member, current). committee_id=alpha:committee:rein-therapeutics-inc:audit-chair-compensation - Audit; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Josef H. von Rickenbach (member, current). committee_id=alpha:committee:rein-therapeutics-inc:audit-nominating-and-governance - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Alan A. Musso (member, current); William C. Fairey (member, current). committee_id=alpha:committee:rein-therapeutics-inc:compensation - Compensation; Nominating and Governance · Chair (compensation). Chair: NOT_PUBLISHED. Members: William C. Fairey (member, current). committee_id=alpha:committee:rein-therapeutics-inc:compensation-nominating-and-governance-chair - Nominating and Governance (nominating_governance). Chair: William C. Fairey. Members: William C. Fairey (chair, current); Josef H. von Rickenbach (member, current). committee_id=alpha:committee:rein-therapeutics-inc:nominating-and-governance ## Executive leadership - Brian Windsor, Ph.D.: President, Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:11 - Timothy M. Cunningham: Interim Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:12 ## Governance events - CEO_CHANGED: Brian Windsor, Ph.D. executive of Rein Therapeutics, Inc., effective 2025-05-12. Effective: 2025-05-12. Detected: 2026-10-18T07:13:20.270492+00:00. event_id=alpha:event:transition:naqih3rpau9x - CFO_CHANGED: Timothy M. Cunningham executive of Rein Therapeutics, Inc., effective 2025-05-12. Effective: 2025-05-12. Detected: 2026-10-18T07:13:20.270492+00:00. event_id=alpha:event:transition:1j099zr15n563d - DIRECTOR_APPOINTED: Alan A. Musso seat on Rein Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-18T07:13:20.270492+00:00. event_id=alpha:event:transition:phwcs6ojmnuw - DIRECTOR_APPOINTED: Brian Windsor, Ph.D. seat on Rein Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-18T07:13:20.270492+00:00. event_id=alpha:event:transition:1qbmx134tjeon - DIRECTOR_APPOINTED: William C. Fairey seat on Rein Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-18T07:13:20.270492+00:00. event_id=alpha:event:transition:44o1r61xdjqmk - COMMITTEE_CREATED: Audit · Chair; Compensation committee of Rein Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-18T07:13:20.270492+00:00. event_id=alpha:event:transition:1camc6o1so7pf0 - COMMITTEE_MEMBER_ADDED: Alan A. Musso member of Audit · Chair; Compensation, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-18T07:13:20.270492+00:00. event_id=alpha:event:transition:t743iyr047e - COMMITTEE_CREATED: Compensation; Nominating and Governance · Chair committee of Rein Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-18T07:13:20.270492+00:00. event_id=alpha:event:transition:11gdvosw4s7m0 - COMMITTEE_MEMBER_ADDED: William C. Fairey member of Compensation; Nominating and Governance · Chair, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-18T07:13:20.270492+00:00. event_id=alpha:event:transition:10x3jpc19i1wdc - DIRECTOR_APPOINTED: Josef H. von Rickenbach seat on Rein Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-18T07:13:20.270492+00:00. event_id=alpha:event:transition:12sh7hr12ihjnz - COMMITTEE_CREATED: Audit; Nominating and Governance committee of Rein Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-18T07:13:20.270492+00:00. event_id=alpha:event:transition:jeaprt199vkzn - COMMITTEE_MEMBER_ADDED: Josef H. von Rickenbach member of Audit; Nominating and Governance, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-18T07:13:20.270492+00:00. event_id=alpha:event:transition:jw4immlqcsde - DIRECTOR_APPOINTED: Manuel C. Alves Aivado, M.D., Ph.D. seat on Rein Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-18T07:13:20.270492+00:00. event_id=alpha:event:transition:4d52l3tc8r7p - DIRECTOR_APPOINTED: Reinhard J. Ambros, Ph.D. seat on Rein Therapeutics, Inc., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-18T07:13:20.270492+00:00. event_id=alpha:event:transition:1r6jvf7838n77 ## Scoped resources - `alpha://company/rein-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record - `alpha://company/rein-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=identity - `alpha://company/rein-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/rein-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=board - `alpha://company/rein-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=committees - `alpha://company/rein-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=leadership - `alpha://company/rein-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=ownership - `alpha://company/rein-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=financials - `alpha://company/rein-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/rein-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=compensation - `alpha://company/rein-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=governance - `alpha://company/rein-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/rein-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=audit - `alpha://company/rein-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=legal - `alpha://company/rein-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=risk - `alpha://company/rein-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=cyber - `alpha://company/rein-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/rein-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=agents - `alpha://company/rein-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/rein-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=events - `alpha://company/rein-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=relationships - `alpha://company/rein-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=assessments - `alpha://company/rein-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:alan-a-musso","name":"Alan A. Musso"},"source_id":"board_seats"}` - Claim alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:josef-h-von-rickenbach","name":"Josef H. von Rickenbach"},"source_id":"board_seats"}` - Claim alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:alan-a-musso","name":"Alan A. Musso"},"source_id":"board_seats"}` - Claim alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:william-c-fairey","name":"William C. Fairey"},"source_id":"board_seats"}` - Claim alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:william-c-fairey","name":"William C. Fairey"},"source_id":"board_seats"}` - Claim alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:josef-h-von-rickenbach","name":"Josef H. von Rickenbach"},"source_id":"board_seats"}` ## Leadership - Alan A. Musso: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:5. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c8f0eb35b77b5138a5f982342796e015bb1d62dc9ede23a5aafd3a6bd3986cd1. - Brian Windsor, Ph.D.: Director. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c8f0eb35b77b5138a5f982342796e015bb1d62dc9ede23a5aafd3a6bd3986cd1. - Josef H. von Rickenbach: Director, Audit; Nominating and Governance. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:7. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c8f0eb35b77b5138a5f982342796e015bb1d62dc9ede23a5aafd3a6bd3986cd1. - Manuel C. Alves Aivado, M.D., Ph.D.: Director. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:8. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c8f0eb35b77b5138a5f982342796e015bb1d62dc9ede23a5aafd3a6bd3986cd1. - Reinhard J. Ambros, Ph.D.: Director. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:9. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c8f0eb35b77b5138a5f982342796e015bb1d62dc9ede23a5aafd3a6bd3986cd1. - William C. Fairey: Director, Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:10. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c8f0eb35b77b5138a5f982342796e015bb1d62dc9ede23a5aafd3a6bd3986cd1. - Brian Windsor, Ph.D.: President, Chief Executive Officer and Director. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:11. Valid from: 2025-05-12. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:244eb8e980a11fd89101ab246c30190e197670a082cb48ee3aa56b41f638cf0f. - Timothy M. Cunningham: Interim Chief Financial Officer. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:leadership_role:12. Valid from: 2025-05-12. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81551e5e18aa49098fe264a1f46564fa3bc99fee6c64ec831a364b9fde6f32f6. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Alan A. Musso; Members Alan A. Musso (Chair); Josef H. von Rickenbach. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:02f2aeb444e38cb352dd00e0966ebff5bf2487be1f7474c0f3d77c84a5319a10. - Compensation: Chair not stated; Members Alan A. Musso; William C. Fairey. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:02f2aeb444e38cb352dd00e0966ebff5bf2487be1f7474c0f3d77c84a5319a10. - Nominating and Governance: Chair William C. Fairey; Members William C. Fairey (Chair); Josef H. von Rickenbach. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:02f2aeb444e38cb352dd00e0966ebff5bf2487be1f7474c0f3d77c84a5319a10. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Rein Therapeutics, Inc.. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6a7afebf07a33af043e0a6a51df3e28ef94ec507de44bd4d7cf6ed2e1b33ec12. ## Entity Status - Public listing published. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6a7afebf07a33af043e0a6a51df3e28ef94ec507de44bd4d7cf6ed2e1b33ec12. ## Published Fact - US. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6a7afebf07a33af043e0a6a51df3e28ef94ec507de44bd4d7cf6ed2e1b33ec12. ## Committee Appointment - Alan A. Musso: chair, Audit. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:02f2aeb444e38cb352dd00e0966ebff5bf2487be1f7474c0f3d77c84a5319a10. - Josef H. von Rickenbach: member, Audit. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:02f2aeb444e38cb352dd00e0966ebff5bf2487be1f7474c0f3d77c84a5319a10. - Alan A. Musso: member, Compensation. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:02f2aeb444e38cb352dd00e0966ebff5bf2487be1f7474c0f3d77c84a5319a10. - William C. Fairey: member, Compensation. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:02f2aeb444e38cb352dd00e0966ebff5bf2487be1f7474c0f3d77c84a5319a10. - William C. Fairey: chair, Nominating and Governance. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:02f2aeb444e38cb352dd00e0966ebff5bf2487be1f7474c0f3d77c84a5319a10. - Josef H. von Rickenbach: member, Nominating and Governance. Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:02f2aeb444e38cb352dd00e0966ebff5bf2487be1f7474c0f3d77c84a5319a10. ## Security Listing - RNTX (NASDAQ). Claim: alpha:claim:company:67998b7c-0281-4502-838a-bd3dac6c8ea2:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6a7afebf07a33af043e0a6a51df3e28ef94ec507de44bd4d7cf6ed2e1b33ec12. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:6a7afebf07a33af043e0a6a51df3e28ef94ec507de44bd4d7cf6ed2e1b33ec12: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/rein-therapeutics-inc). - alpha:projection-evidence:document:c8f0eb35b77b5138a5f982342796e015bb1d62dc9ede23a5aafd3a6bd3986cd1: [Rein Therapeutics, Inc. DEF 14A 2025-05-12](https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm). - alpha:projection-evidence:document:244eb8e980a11fd89101ab246c30190e197670a082cb48ee3aa56b41f638cf0f: [RNTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm). - alpha:projection-evidence:document:81551e5e18aa49098fe264a1f46564fa3bc99fee6c64ec831a364b9fde6f32f6: [RNTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm). - alpha:projection-evidence:02f2aeb444e38cb352dd00e0966ebff5bf2487be1f7474c0f3d77c84a5319a10: [Audit](https://www.sec.gov/Archives/edgar/data/1420565/000119312525117820/d895609ddef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/rein-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/rein-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/rein-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/rein-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-18T09:21:42.253555+00:00; recorded 2026-10-18T09:21:42.253555+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.